Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA [Yahoo! Finance]
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA
Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) [Yahoo! Finance]
Achieve Life Sciences, Inc. (NASDAQ: ACHV) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.